Functional Microrobots Could Harbor Bioengineering Apps
By HospiMedica International staff writers Posted on 22 May 2017 |
Image: A bullet-shape microrobot with a programmed inner cavity, swimming in 5% H2O2 (Photo courtesy of Max Planck Institute).
A new study suggests that untethered micron-scale mobile robots can navigate and non-invasively perform specific tasks inside hard-to-reach body sites.
Currently being designed, fabricated, and tested at the Max Planck Institute for Intelligent Systems and Carnegie Mellon University, the first-generation microrobots will be able to deliver therapeutics and other cargo to targeted body sites, as well as to enclosed organ-on-a-chip microfluidic devices with live cells. A new two-step approach is use to provide the microrobotic devices with desirable functions. The first step uses three-dimensional (3D) laser lithography to crosslink light-responsive polymers.
In the second step, the formed chemically homogenous base structure is functionalized by modifying it at specific geometric sites with chemically compatible small molecules which introduce new chemical groups using selective 3D laser lithography illumination; this causes an unreacted polymer precursor to be removed, and a new precursor with the desired chemical functionality is introduced in its place. The technique allows the microrobots to be fabricated with high versatility.
To prove the concept, the researchers prepared a bullet-shaped micro-swimmer, in which an inner cavity was selectively modified with catalytic platinum nanoparticles. The researchers also designed a microflower structure bearing orthogonal biotin, thiol, and alkyne groups at precisely defined positions. According to the researchers, the new sub-millimeter constructs hold a myriad of applications in various fields besides microrobots, including targeted delivery, tissue engineering, self-organizing systems, programmable matter, and soft microactuators. The study was published on May 8, 2017, in Lab Chip.
“Our key objective is to develop new methods of making miniaturized materials that are performing intelligently in complex and unstable environment,” said lead author postdoctoral researcher Hakan Ceylan, PhD, of the Max Planck Institute. “In the near future, probably in around 10 years, this could have tremendous applications in tissue engineering and regenerative medicine, while in the longer term, it could revolutionize the treatment of genetic diseases by single cell-level protein or nucleic acid delivery.”
Currently being designed, fabricated, and tested at the Max Planck Institute for Intelligent Systems and Carnegie Mellon University, the first-generation microrobots will be able to deliver therapeutics and other cargo to targeted body sites, as well as to enclosed organ-on-a-chip microfluidic devices with live cells. A new two-step approach is use to provide the microrobotic devices with desirable functions. The first step uses three-dimensional (3D) laser lithography to crosslink light-responsive polymers.
In the second step, the formed chemically homogenous base structure is functionalized by modifying it at specific geometric sites with chemically compatible small molecules which introduce new chemical groups using selective 3D laser lithography illumination; this causes an unreacted polymer precursor to be removed, and a new precursor with the desired chemical functionality is introduced in its place. The technique allows the microrobots to be fabricated with high versatility.
To prove the concept, the researchers prepared a bullet-shaped micro-swimmer, in which an inner cavity was selectively modified with catalytic platinum nanoparticles. The researchers also designed a microflower structure bearing orthogonal biotin, thiol, and alkyne groups at precisely defined positions. According to the researchers, the new sub-millimeter constructs hold a myriad of applications in various fields besides microrobots, including targeted delivery, tissue engineering, self-organizing systems, programmable matter, and soft microactuators. The study was published on May 8, 2017, in Lab Chip.
“Our key objective is to develop new methods of making miniaturized materials that are performing intelligently in complex and unstable environment,” said lead author postdoctoral researcher Hakan Ceylan, PhD, of the Max Planck Institute. “In the near future, probably in around 10 years, this could have tremendous applications in tissue engineering and regenerative medicine, while in the longer term, it could revolutionize the treatment of genetic diseases by single cell-level protein or nucleic acid delivery.”
Latest Health IT News
- Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients
- Strategic Collaboration to Develop and Integrate Generative AI into Healthcare
- AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity
- AI Predicts Pancreatic Cancer Three Years before Diagnosis from Patients’ Medical Records
- First Fully Autonomous Generative AI Personalized Medical Authorizations System Reduces Care Delay
- Electronic Health Records May Be Key to Improving Patient Care, Study Finds
- AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease
- First-Ever AI Test for Early Diagnosis of Alzheimer’s to Be Expanded to Diagnosis of Parkinson’s Disease
- New Self-Learning AI-Based Algorithm Reads Electrocardiograms to Spot Unseen Signs of Heart Failure
- Autonomous Robot Performs COVID-19 Nasal Swab Tests
- Statistical Tool Predicts COVID-19 Peaks Worldwide
- Wireless-Controlled Soft Neural Implant Stimulates Brain Cells
- Tiny Polymer Stent Could Treat Pediatric Urethral Strictures
- Human Torso Simulator Helps Design Brace Innovations
- 3D Bioprinting Rebuilds the Human Heart
- Nanodrone Detects Toxic Gases in Hazardous Environments